Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
94.61
-0.06 (-0.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Merit Medical Systems stock have an average target of 109, with a low estimate of 100 and a high estimate of 120. The average target predicts an increase of 15.21% from the current stock price of 94.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $127 → $108 | Strong Buy | Maintains | $127 → $108 | +14.15% | Apr 25, 2025 |
| Raymond James | Raymond James | Buy Maintains $116 → $108 | Buy | Maintains | $116 → $108 | +14.15% | Apr 25, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $111 → $103 | Buy | Maintains | $111 → $103 | +8.87% | Apr 25, 2025 |
| Needham | Needham | Strong Buy Maintains $116 → $100 | Strong Buy | Maintains | $116 → $100 | +5.70% | Apr 25, 2025 |
| Baird | Baird | Buy Maintains $111 → $110 | Buy | Maintains | $111 → $110 | +16.27% | Apr 25, 2025 |
Financial Forecast
Revenue This Year
1.51B
from 1.36B
Increased by 11.31%
Revenue Next Year
1.60B
from 1.51B
Increased by 6.09%
EPS This Year
3.72
from 2.03
Increased by 83.30%
EPS Next Year
4.15
from 3.72
Increased by 11.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6B | 1.7B | 1.8B | ||
| Avg | 1.5B | 1.6B | 1.7B | ||
| Low | 1.4B | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 10.5% | 11.2% | ||
| Avg | 11.3% | 6.1% | 6.0% | ||
| Low | 6.4% | 0.3% | -0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.89 | 4.40 | 4.70 | ||
| Avg | 3.72 | 4.15 | 4.44 | ||
| Low | 3.53 | 3.92 | 4.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 91.4% | 18.2% | 13.3% | ||
| Avg | 83.3% | 11.5% | 7.0% | ||
| Low | 73.8% | 5.3% | -1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.